Trending Topic

22 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare, autoimmune neurological disorder in which peripheral nerve demyelination typically results in weakness, impaired limb sensation, fatigue and pain.1–4 CIDP may adversely affect activities of daily living, with a substantial impact on functional ability and psychological well-being.2–6 Primary treatment goals are reducing symptoms, improving functional status and maintaining long-term remission.7 The […]

touchSERIES

Smoldering Neuroinflammation in Multiple Sclerosis

Hear from your peers about smoldering neuroinflammation and disability.
Browse these important smoldering neuroinflammation topics, presented by experts in MS at key global conferences.

50 mins
Sponsored Content
touchMEETING HIGHLIGHTS
For HCPs in: Spain, Belgium, Netherlands, Sweden, Finland, Norway, Denmark and Italy

Sanofi at ECTRIMS 2024. Join MS experts as they examine disability accumulation through the lens of personalised care, biomarkers, and clinical trial design. Hear their perspectives on the complexities of balancing improved relapse management with the ongoing challenge of disability accumulation.

58 mins
Sponsored Content
touchMEETING HIGHLIGHTS
For HCPs in: Spain, Belgium, Netherlands, Sweden, Finland, Norway, Denmark and Italy

Sanofi at EAN 2024. Hear from the experts about our evolving understanding of multiple sclerosis pathophysiology and the role of smoldering neuroinflammation, with a closer look at microglia and BTK.

78 mins
Sponsored Content
touchMEETING HIGHLIGHTS
For HCPs in: Spain, Belgium, Netherlands, Sweden, Finland, Norway, Denmark and Italy

Sanofi at AAN 2024. Join MS experts as they examine the role of smoldering neuroinflammation and its underlying biology, with a closer look at microglia and BTK.

56 mins
Sponsored Content
touchMEETING HIGHLIGHTS
For HCPs in: Spain, Belgium, Netherlands, Sweden, Finland, Norway, Denmark and Italy

Sanofi at ECTRIMS 2023. Explore smoldering neuroinflammation, which results in physical and cognitive disability accumulation, and its impact on your patients.

83 mins
Sponsored Content
touchMEETING HIGHLIGHTS
For HCPs in: Spain, Belgium, Netherlands, Sweden, Finland, Norway, Denmark and Italy

Sanofi at AAN 2023. Explore perspectives on MS disability accumulation in the time of highly effective therapies, the smoldering neuroinflammatory pathway, and CNS biomarkers of the future in this Industry Therapeutic Update.

59 mins
Sponsored Content
touchMEETING HIGHLIGHTS
For HCPs in: Spain, Belgium, Netherlands, Sweden, Finland, Norway, Denmark and Italy

Sanofi at EAN 2023. Learn about the drivers of multiple sclerosis disability accumulation, the unique role of smoldering neuroinflammation, and the role of “big data” in central nervous system biomarkers of the future.

External site.


 

This touchSERIES is sponsored by Sanofi.

Sanofi provided financial support and video content, and has had input into the detailed scope for each activity. This touchSERIES is provided by Touch Medical Communications (TMC) for touchNEUROLOGY.

Unapproved products or unapproved uses of approved products may be discussed; these situations may reflect the approval status in one or more jurisdictions. TMC has advised the sponsor to ensure that they disclose any such references made to unlabelled or unapproved use. No endorsement by TMC of any unapproved products or unapproved uses is either made or implied by mention of these products or uses in TMC activities. TMC accepts no responsibility for errors or omissions.

The views and opinions expressed are those of the faculty and do not necessarily reflect those of any sponsor.

MAT-GLB-2301631-v3-11/2024
Date of preparation: December 2024

Close Popup